• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病、炎症与共病——一种常见的炎症表型?

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

作者信息

Sevenoaks Martin J, Stockley Robert A

机构信息

Department of Medicine, Queen Elizabeth Hospital Birmingham, UK.

出版信息

Respir Res. 2006 May 2;7(1):70. doi: 10.1186/1465-9921-7-70.

DOI:10.1186/1465-9921-7-70
PMID:16669999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1479815/
Abstract

Chronic Obstructive Pulmonary Disease (COPD) is and will remain a major cause of morbidity and mortality worldwide. The severity of airflow obstruction is known to relate to overall health status and mortality. However, even allowing for common aetiological factors, a link has been identified between COPD and other systemic diseases such as cardiovascular disease, diabetes and osteoporosis. COPD is known to be an inflammatory condition and neutrophil elastase has long been considered a significant mediator of the disease. Pro-inflammatory cytokines, in particular TNF-alpha (Tumour Necrosis Factor alpha), may be the driving force behind the disease process. However, the roles of inflammation and these pro-inflammatory cytokines may extend beyond the lungs and play a part in the systemic effects of the disease and associated co-morbidities. This article describes the mechanisms involved and proposes a common inflammatory TNF-alpha phenotype that may, in part, account for the associations.

摘要

慢性阻塞性肺疾病(COPD)过去是、将来仍将是全球发病和死亡的主要原因。气流阻塞的严重程度与整体健康状况和死亡率相关。然而,即便考虑到常见的病因,慢性阻塞性肺疾病与其他全身性疾病(如心血管疾病、糖尿病和骨质疏松症)之间的联系也已得到确认。众所周知,慢性阻塞性肺疾病是一种炎症性疾病,中性粒细胞弹性蛋白酶长期以来一直被认为是该疾病的重要介质。促炎细胞因子,特别是肿瘤坏死因子-α(TNF-α),可能是疾病进程背后的驱动力。然而,炎症和这些促炎细胞因子的作用可能不仅限于肺部,还在该疾病的全身影响及相关合并症中发挥作用。本文描述了其中涉及的机制,并提出了一种常见的炎症性肿瘤坏死因子-α表型,这可能部分解释了这些关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/eef906e8459c/1465-9921-7-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/72c457f90df0/1465-9921-7-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/a528e5a8832b/1465-9921-7-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/043b5fc1eb58/1465-9921-7-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/eef906e8459c/1465-9921-7-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/72c457f90df0/1465-9921-7-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/a528e5a8832b/1465-9921-7-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/043b5fc1eb58/1465-9921-7-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/1479815/eef906e8459c/1465-9921-7-70-4.jpg

相似文献

1
Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?慢性阻塞性肺疾病、炎症与共病——一种常见的炎症表型?
Respir Res. 2006 May 2;7(1):70. doi: 10.1186/1465-9921-7-70.
2
The association of low bone mineral density with systemic inflammation in clinically stable COPD.慢性阻塞性肺疾病稳定期患者低骨密度与全身炎症的相关性。
Endocrine. 2012 Aug;42(1):190-5. doi: 10.1007/s12020-011-9583-x. Epub 2011 Dec 24.
3
[The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].[炎症过程对稳定期慢性阻塞性肺疾病患者通气功能损害的影响]
Pneumonol Alergol Pol. 2010;78(4):271-8.
4
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.C反应蛋白作为稳定期慢性阻塞性肺疾病全身炎症标志物的价值
Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.
5
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.慢性阻塞性肺疾病作为一种具有全身影响的肺部疾病——临床影响、机制及早期干预潜力
COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531.
6
Systemic inflammation in patients with COPD and pulmonary hypertension.慢性阻塞性肺疾病(COPD)合并肺动脉高压患者的全身炎症
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.
7
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.慢性阻塞性肺疾病严重程度与潜在生物标志物的相关性。
Immunol Lett. 2018 Apr;196:1-10. doi: 10.1016/j.imlet.2018.01.004. Epub 2018 Jan 9.
8
Shared mechanisms of multimorbidity in COPD, atherosclerosis and type-2 diabetes: the neutrophil as a potential inflammatory target.COPD、动脉粥样硬化和 2 型糖尿病中多种疾病共病的共同机制:中性粒细胞作为潜在的炎症靶点。
Eur Respir Rev. 2020 Mar 20;29(155). doi: 10.1183/16000617.0102-2019. Print 2020 Mar 31.
9
Exercise alleviates depression related systemic inflammation in chronic obstructive pulmonary disease patients.运动可减轻慢性阻塞性肺疾病患者与抑郁相关的全身炎症。
Afr Health Sci. 2016 Dec;16(4):1078-1088. doi: 10.4314/ahs.v16i4.25.
10
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.基于验证性客观测量和全身炎症的慢性阻塞性肺疾病患者的共病群。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.

引用本文的文献

1
Inflammatory lung diseases: a clinical and scientific review of the latest advances and challenges.炎症性肺部疾病:最新进展与挑战的临床与科学综述
Pharmacol Rep. 2025 Jun 13. doi: 10.1007/s43440-025-00749-y.
2
Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis.β受体阻滞剂的使用对合并心血管疾病的慢性阻塞性肺疾病的影响:系统评价与荟萃分析
Tuberc Respir Dis (Seoul). 2024 Jul;87(3):261-281. doi: 10.4046/trd.2024.0013. Epub 2024 Apr 4.
3
Identification of non-small cell lung cancer with chronic obstructive pulmonary disease using clinical symptoms and routine examination: a retrospective study.

本文引用的文献

1
Cancer cachexia.癌症恶病质
QJM. 2005 Nov;98(11):779-88. doi: 10.1093/qjmed/hci127. Epub 2005 Oct 7.
2
The metabolic syndrome--a new worldwide definition.代谢综合征——一个新的全球定义。
Lancet. 2005;366(9491):1059-62. doi: 10.1016/S0140-6736(05)67402-8.
3
Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.慢性阻塞性肺疾病作为心血管疾病发病和死亡的危险因素。
利用临床症状和常规检查鉴别非小细胞肺癌合并慢性阻塞性肺疾病:一项回顾性研究
Front Oncol. 2023 Jul 28;13:1158948. doi: 10.3389/fonc.2023.1158948. eCollection 2023.
4
Protocol for a systematic review of the associations between inflammatory markers and lung function, muscle force and exercise capacity in people with COPD.中文译文:COPD 患者炎症标志物与肺功能、肌肉力量和运动能力相关性的系统评价方案。
BMJ Open. 2023 Jul 18;13(7):e068776. doi: 10.1136/bmjopen-2022-068776.
5
The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease.双向肠-肺轴在慢性阻塞性肺疾病中的作用
Am J Respir Crit Care Med. 2023 May 1;207(9):1145-1160. doi: 10.1164/rccm.202206-1066TR.
6
Anti-Inflammatory and Antioxidant Properties of L. Extracts and : Potential Application for Skin Care.L.提取物的抗炎和抗氧化特性及:在皮肤护理中的潜在应用。 需注意,原文中“and :”表述不太清晰准确,可能存在信息缺失或有误的情况,但按照要求进行了逐字翻译。
Evid Based Complement Alternat Med. 2022 Oct 19;2022:7579572. doi: 10.1155/2022/7579572. eCollection 2022.
7
Health-Screening-Based Chronic Obstructive Pulmonary Disease and Its Effect on Cardiovascular Disease Risk.基于健康筛查的慢性阻塞性肺疾病及其对心血管疾病风险的影响。
J Clin Med. 2022 Jun 2;11(11):3181. doi: 10.3390/jcm11113181.
8
Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action.医用大麻对炎症的作用:活性成分与作用方式。
Front Pharmacol. 2022 May 9;13:908198. doi: 10.3389/fphar.2022.908198. eCollection 2022.
9
Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy.C 反应蛋白与 2 型糖尿病视网膜病变患者呼吸系统疾病的关系。
Med Sci Monit. 2022 May 17;28:e935807. doi: 10.12659/MSM.935807.
10
Is obstructive sleep apnea associated with increased arterial stiffness in patients with COPD?阻塞性睡眠呼吸暂停与 COPD 患者的动脉僵硬有关吗?
Sleep Breath. 2023 May;27(2):765-770. doi: 10.1007/s11325-022-02635-w. Epub 2022 May 11.
Proc Am Thorac Soc. 2005;2(1):8-11. doi: 10.1513/pats.200404-032MS.
4
Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects.人主动脉内皮细胞上的Fcγ受体对C反应蛋白的结合与内化介导生物学效应。
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1359-63. doi: 10.1161/01.ATV.0000168573.10844.ae. Epub 2005 Apr 28.
5
TNFR2 gene polymorphism in coronary artery disease.冠状动脉疾病中的肿瘤坏死因子受体2(TNFR2)基因多态性
Indian J Med Sci. 2005 Mar;59(3):104-8.
6
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males.健康中年男性26年随访中的肺功能、吸烟与死亡率
Eur Respir J. 2005 Apr;25(4):618-25. doi: 10.1183/09031936.05.00008504.
7
Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease.重度慢性阻塞性肺疾病中的氧化应激与呼吸肌功能障碍
Am J Respir Crit Care Med. 2005 May 15;171(10):1116-24. doi: 10.1164/rccm.200407-887OC. Epub 2005 Feb 25.
8
Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的幽门螺杆菌血清阳性率
Respir Med. 2005 Mar;99(3):279-84. doi: 10.1016/j.rmed.2004.08.007.
9
Risk of myocardial infarction and stroke after acute infection or vaccination.急性感染或接种疫苗后发生心肌梗死和中风的风险。
N Engl J Med. 2004 Dec 16;351(25):2611-8. doi: 10.1056/NEJMoa041747.
10
Inflammatory markers and the risk of coronary heart disease in men and women.炎症标志物与男性和女性冠心病风险
N Engl J Med. 2004 Dec 16;351(25):2599-610. doi: 10.1056/NEJMoa040967.